These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 9524773

  • 1. HGF/SF in angiogenesis.
    Rosen EM, Lamszus K, Laterra J, Polverini PJ, Rubin JS, Goldberg ID.
    Ciba Found Symp; 1997; 212():215-26; discussion 227-9. PubMed ID: 9524773
    [Abstract] [Full Text] [Related]

  • 2. Scatter factor and angiogenesis.
    Rosen EM, Goldberg ID.
    Adv Cancer Res; 1995; 67():257-79. PubMed ID: 8571817
    [Abstract] [Full Text] [Related]

  • 3. Regulation of angiogenesis by scatter factor.
    Rosen EM, Goldberg ID.
    EXS; 1997; 79():193-208. PubMed ID: 9002233
    [Abstract] [Full Text] [Related]

  • 4. Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas.
    Lamszus K, Laterra J, Westphal M, Rosen EM.
    Int J Dev Neurosci; 1999; 17(5-6):517-30. PubMed ID: 10571413
    [Abstract] [Full Text] [Related]

  • 5. Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo.
    Rosen EM, Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P.
    Symp Soc Exp Biol; 1993; 47():227-34. PubMed ID: 8165567
    [Abstract] [Full Text] [Related]

  • 6. Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma.
    Tolnay E, Kuhnen C, Wiethege T, König JE, Voss B, Müller KM.
    J Cancer Res Clin Oncol; 1998; 124(6):291-6. PubMed ID: 9692834
    [Abstract] [Full Text] [Related]

  • 7. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor.
    Sengupta S, Gherardi E, Sellers LA, Wood JM, Sasisekharan R, Fan TP.
    Arterioscler Thromb Vasc Biol; 2003 Jan 01; 23(1):69-75. PubMed ID: 12524227
    [Abstract] [Full Text] [Related]

  • 8. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist.
    Martin TA, Parr C, Davies G, Watkins G, Lane J, Matsumoto K, Nakamura T, Mansel RE, Jiang WG.
    Carcinogenesis; 2003 Aug 01; 24(8):1317-23. PubMed ID: 12807719
    [Abstract] [Full Text] [Related]

  • 9. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K, Jin L, Fuchs A, Shi E, Chowdhury S, Yao Y, Polverini PJ, Laterra J, Goldberg ID, Rosen EM.
    Lab Invest; 1997 Mar 01; 76(3):339-53. PubMed ID: 9121117
    [Abstract] [Full Text] [Related]

  • 10. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
    Hu B, Guo P, Bar-Joseph I, Imanishi Y, Jarzynka MJ, Bogler O, Mikkelsen T, Hirose T, Nishikawa R, Cheng SY.
    Oncogene; 2007 Aug 16; 26(38):5577-86. PubMed ID: 17369861
    [Abstract] [Full Text] [Related]

  • 11. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP.
    Cancer Res; 2003 Dec 01; 63(23):8351-9. PubMed ID: 14678996
    [Abstract] [Full Text] [Related]

  • 12. Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer.
    Nagy J, Curry GW, Hillan KJ, McKay IC, Mallon E, Purushotham AD, George WD.
    Surg Oncol; 1996 Feb 01; 5(1):15-21. PubMed ID: 8837300
    [Abstract] [Full Text] [Related]

  • 13. The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).
    To CT, Tsao MS.
    Oncol Rep; 1998 Feb 01; 5(5):1013-24. PubMed ID: 9683803
    [Abstract] [Full Text] [Related]

  • 14. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM, Hartmann G, Naldini L, Comoglio PM, Sachs M, Fonatsch C, Rieder H, Birchmeier W.
    EXS; 1993 Feb 01; 65():311-28. PubMed ID: 8380739
    [Abstract] [Full Text] [Related]

  • 15. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.
    Jiang WG, Hiscox SE, Parr C, Martin TA, Matsumoto K, Nakamura T, Mansel RE.
    Clin Cancer Res; 1999 Nov 01; 5(11):3695-703. PubMed ID: 10589789
    [Abstract] [Full Text] [Related]

  • 16. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.
    Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, Isner JM.
    Circulation; 1998 Feb 03; 97(4):381-90. PubMed ID: 9468212
    [Abstract] [Full Text] [Related]

  • 17. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells.
    Weidner KM, Sachs M, Birchmeier W.
    J Cell Biol; 1993 Apr 03; 121(1):145-54. PubMed ID: 8384622
    [Abstract] [Full Text] [Related]

  • 18. Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells.
    Parr C, Hiscox S, Nakamura T, Matsumoto K, Jiang WG.
    Int J Cancer; 2000 Feb 15; 85(4):563-70. PubMed ID: 10699931
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH.
    Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973
    [Abstract] [Full Text] [Related]

  • 20. Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis.
    Abounader R, Laterra J.
    Neuro Oncol; 2005 Oct 15; 7(4):436-51. PubMed ID: 16212809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.